|
1
|
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.
|
Eur J Nucl Med Mol Imaging
|
2008
|
2.55
|
|
2
|
False positive and false negative FDG-PET scans in various thoracic diseases.
|
Korean J Radiol
|
2006
|
2.46
|
|
3
|
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
|
Cancer
|
2012
|
1.84
|
|
4
|
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
|
J Nucl Med
|
2006
|
1.72
|
|
5
|
Molecular-genetic imaging based on reporter gene expression.
|
J Nucl Med
|
2008
|
1.64
|
|
6
|
Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
|
J Nucl Med
|
2005
|
1.59
|
|
7
|
PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness.
|
J Nucl Med
|
2003
|
1.52
|
|
8
|
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
|
Eur J Nucl Med Mol Imaging
|
2014
|
1.48
|
|
9
|
Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.
|
Thyroid
|
2013
|
1.46
|
|
10
|
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation.
|
J Thorac Oncol
|
2015
|
1.44
|
|
11
|
Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
|
J Surg Oncol
|
2006
|
1.42
|
|
12
|
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
|
J Nucl Med
|
2008
|
1.32
|
|
13
|
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
|
J Nucl Med
|
2009
|
1.30
|
|
14
|
Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation.
|
J Nucl Med
|
2008
|
1.29
|
|
15
|
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
|
Ann Surg Oncol
|
2011
|
1.28
|
|
16
|
Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
|
Small
|
2011
|
1.23
|
|
17
|
In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.
|
J Nucl Med
|
2008
|
1.17
|
|
18
|
Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching.
|
Surgery
|
2011
|
1.15
|
|
19
|
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
|
Gynecol Oncol
|
2006
|
1.13
|
|
20
|
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.09
|
|
21
|
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.
|
J Nucl Med
|
2003
|
1.08
|
|
22
|
A decade of the asian regional cooperative council for nuclear medicine: a path to reduce heterogeneity of nuclear medicine practice in Asia.
|
World J Nucl Med
|
2011
|
1.07
|
|
23
|
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.06
|
|
24
|
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
|
Gynecol Oncol
|
2010
|
1.06
|
|
25
|
Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.05
|
|
26
|
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
|
Eur J Radiol
|
2007
|
1.04
|
|
27
|
Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
|
Breast
|
2011
|
1.04
|
|
28
|
(18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis.
|
J Nucl Med
|
2002
|
1.04
|
|
29
|
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
|
Eur J Nucl Med Mol Imaging
|
2004
|
1.02
|
|
30
|
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.
|
Eur J Nucl Med Mol Imaging
|
2014
|
1.01
|
|
31
|
Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
|
Radiology
|
2006
|
0.99
|
|
32
|
Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.
|
Thyroid
|
2013
|
0.99
|
|
33
|
Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method.
|
Bioconjug Chem
|
2005
|
0.99
|
|
34
|
The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.99
|
|
35
|
Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication.
|
Clin Nucl Med
|
2013
|
0.99
|
|
36
|
Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment.
|
Hum Brain Mapp
|
2005
|
0.98
|
|
37
|
Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status.
|
J Korean Med Sci
|
2008
|
0.97
|
|
38
|
Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.95
|
|
39
|
In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.
|
Mol Imaging Biol
|
2008
|
0.95
|
|
40
|
Immune response to firefly luciferase as a naked DNA.
|
Cancer Biol Ther
|
2007
|
0.95
|
|
41
|
Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT.
|
J Nucl Med
|
2004
|
0.95
|
|
42
|
Rapid synthesis of [18F]FDG without an evaporation step using an ionic liquid.
|
Appl Radiat Isot
|
2004
|
0.94
|
|
43
|
Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18F-labeling study.
|
Chem Commun (Camb)
|
2011
|
0.93
|
|
44
|
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
|
Acta Radiol
|
2011
|
0.92
|
|
45
|
Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.92
|
|
46
|
Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer.
|
Acta Obstet Gynecol Scand
|
2007
|
0.92
|
|
47
|
Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
|
Hum Gene Ther
|
2008
|
0.91
|
|
48
|
Voxel-based statistical analysis of cerebral glucose metabolism in the rat cortical deafness model by 3D reconstruction of brain from autoradiographic images.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.91
|
|
49
|
Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N'-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging.
|
J Med Chem
|
2012
|
0.90
|
|
50
|
Identification of angiogenesis in primary breast carcinoma according to the image analysis.
|
Breast Cancer Res Treat
|
2002
|
0.90
|
|
51
|
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
|
BMC Cancer
|
2011
|
0.90
|
|
52
|
Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.90
|
|
53
|
Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.90
|
|
54
|
Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results.
|
J Nucl Cardiol
|
2002
|
0.89
|
|
55
|
Reporter gene imaging.
|
AJR Am J Roentgenol
|
2013
|
0.89
|
|
56
|
Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
|
J Nucl Med
|
2007
|
0.89
|
|
57
|
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
|
Lung Cancer
|
2012
|
0.89
|
|
58
|
Diagnostic performance of 18F-FDG PET and ictal 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET.
|
Seizure
|
2005
|
0.89
|
|
59
|
Imaging of integrin α(V)β(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct.
|
Mol Imaging
|
2013
|
0.88
|
|
60
|
Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
|
J Clin Endocrinol Metab
|
2013
|
0.88
|
|
61
|
Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression.
|
J Nucl Med
|
2005
|
0.88
|
|
62
|
The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.
|
Cancer Res Treat
|
2005
|
0.88
|
|
63
|
Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report.
|
Ann Nucl Med
|
2009
|
0.88
|
|
64
|
Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT.
|
BMC Res Notes
|
2011
|
0.87
|
|
65
|
In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
|
Cancer Biol Ther
|
2007
|
0.87
|
|
66
|
In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice.
|
Mol Imaging Biol
|
2009
|
0.87
|
|
67
|
Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2012
|
0.87
|
|
68
|
Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine.
|
Int J Cancer
|
2007
|
0.86
|
|
69
|
Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.
|
Ann Nucl Med
|
2005
|
0.86
|
|
70
|
Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
|
J Nucl Med
|
2004
|
0.86
|
|
71
|
Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
|
Ann Nucl Med
|
2008
|
0.86
|
|
72
|
Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation.
|
Nanomedicine (Lond)
|
2011
|
0.86
|
|
73
|
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.85
|
|
74
|
Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
|
J Nucl Med
|
2002
|
0.85
|
|
75
|
Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials.
|
Cancer Biother Radiopharm
|
2003
|
0.85
|
|
76
|
Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy.
|
Mol Cancer Ther
|
2008
|
0.85
|
|
77
|
Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy.
|
Gynecol Obstet Invest
|
2008
|
0.85
|
|
78
|
Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
|
Bioorg Med Chem
|
2011
|
0.85
|
|
79
|
[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.84
|
|
80
|
Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET: characterization and application to therapeutic efficacy monitoring in rats.
|
Coron Artery Dis
|
2013
|
0.84
|
|
81
|
Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.84
|
|
82
|
MIDGE/hNIS vaccination generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity.
|
Int J Cancer
|
2007
|
0.84
|
|
83
|
Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and application for RGD labeling.
|
Bioorg Med Chem
|
2012
|
0.84
|
|
84
|
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.
|
Cancer Res
|
2006
|
0.83
|
|
85
|
Usefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients.
|
Cancer Res Treat
|
2005
|
0.82
|
|
86
|
In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
|
Thyroid
|
2004
|
0.82
|
|
87
|
Visualization of hypoxia-inducible factor-1 transcriptional activation in C6 glioma using luciferase and sodium iodide symporter genes.
|
J Nucl Med
|
2008
|
0.82
|
|
88
|
Synthesis of novel 68Ga-labeled amino acid derivatives for positron emission tomography of cancer cells.
|
Nucl Med Biol
|
2010
|
0.82
|
|
89
|
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
|
Breast Cancer
|
2012
|
0.82
|
|
90
|
Synthesis and characterization of nitroimidazole derivatives for 68Ga-labeling and testing in tumor xenografted mice.
|
J Med Chem
|
2010
|
0.82
|
|
91
|
The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients.
|
Ann Nucl Med
|
2006
|
0.82
|
|
92
|
Probabilistic map of blood flow distribution in the brain from the internal carotid artery.
|
Neuroimage
|
2004
|
0.82
|
|
93
|
Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.81
|
|
94
|
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
|
Clin Cancer Res
|
2006
|
0.81
|
|
95
|
Novel one-pot one-step synthesis of 2'-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging.
|
Nucl Med Biol
|
2003
|
0.81
|
|
96
|
Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
|
Eur J Radiol
|
2012
|
0.81
|
|
97
|
Translational research using the sodium/iodide symporter in imaging and therapy.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.81
|
|
98
|
Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
|
Nucl Med Biol
|
2006
|
0.81
|
|
99
|
Nanoparticles modified by encapsulation of ligands with a long alkyl chain to affect multispecific and multimodal imaging.
|
J Nucl Med
|
2012
|
0.81
|
|
100
|
In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
|
J Gene Med
|
2012
|
0.81
|
|
101
|
Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer.
|
Ann Nucl Med
|
2014
|
0.81
|
|
102
|
The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.
|
Biomaterials
|
2011
|
0.81
|
|
103
|
Imaging target mRNA and siRNA-mediated gene silencing in vivo with ribozyme-based reporters.
|
Chembiochem
|
2008
|
0.81
|
|
104
|
Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
|
Eur J Nucl Med Mol Imaging
|
2015
|
0.81
|
|
105
|
Formulation of 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study.
|
Nucl Med Biol
|
2009
|
0.81
|
|
106
|
Criteria for definition of regional functional improvement on quantitative post-stress gated myocardial SPET after bypass surgery in patients with ischaemic cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.81
|
|
107
|
In vivo monitoring of DNA vaccine gene expression using firefly luciferase as a naked DNA.
|
Vaccine
|
2006
|
0.81
|
|
108
|
Development and applications of a software for Functional Image Registration (FIRE).
|
Comput Methods Programs Biomed
|
2005
|
0.80
|
|
109
|
Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
|
Nucl Med Commun
|
2014
|
0.80
|
|
110
|
Site-specific 99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain.
|
Arch Pharm Res
|
2004
|
0.80
|
|
111
|
Evaluation of surgical completeness in endoscopic thyroidectomy compared with open thyroidectomy with regard to remnant ablation.
|
Clin Nucl Med
|
2012
|
0.80
|
|
112
|
Changes in the heterogeneity of cerebral glucose metabolism with healthy aging: quantitative assessment by fractal analysis.
|
J Neuroimaging
|
2004
|
0.80
|
|
113
|
Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.80
|
|
114
|
Preparation of (188) Re-labeled paper for treating skin cancer.
|
Appl Radiat Isot
|
2003
|
0.80
|
|
115
|
Superiority of HMPAO ictal SPECT to ECD ictal SPECT in localizing the epileptogenic zone.
|
Epilepsia
|
2002
|
0.80
|
|
116
|
Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer.
|
Endocrine
|
2014
|
0.80
|
|
117
|
Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography.
|
Nucl Med Biol
|
2010
|
0.80
|
|
118
|
Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in vivo atherosclerosis imaging.
|
Ann Nucl Med
|
2013
|
0.80
|
|
119
|
Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
|
Cancer Biother Radiopharm
|
2008
|
0.80
|
|
120
|
Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene.
|
J Nucl Med
|
2004
|
0.80
|
|
121
|
Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis.
|
Ann Nucl Med
|
2015
|
0.80
|
|
122
|
Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma.
|
Ann Nucl Med
|
2008
|
0.80
|
|
123
|
Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
|
Nucl Med Commun
|
2014
|
0.79
|
|
124
|
F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnate scan findings of a patient with unilateral subacute thyroiditis.
|
Clin Nucl Med
|
2009
|
0.79
|
|
125
|
Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
|
J Clin Endocrinol Metab
|
2015
|
0.79
|
|
126
|
The neural correlates of cross-modal interaction in speech perception during a semantic decision task on sentences: a PET study.
|
Neuroimage
|
2006
|
0.79
|
|
127
|
99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
|
Bioconjug Chem
|
2004
|
0.79
|
|
128
|
Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesis.
|
Cancer Biother Radiopharm
|
2010
|
0.79
|
|
129
|
Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography.
|
Bioorg Med Chem
|
2010
|
0.79
|
|
130
|
A new PET probe, (18)F-tetrafluoroborate, for the sodium/iodide symporter: possible impacts on nuclear medicine.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.79
|
|
131
|
In vivo imaging of retinoic acid receptor activity using a sodium/iodide symporter and luciferase dual imaging reporter gene.
|
Mol Imaging
|
2004
|
0.79
|
|
132
|
Prognostic value of rest (201)Tl-dipyridamole stress (99m)Tc-sestamibi gated SPECT for predicting patient-based clinical outcomes after bypass surgery in patients with ischemic left ventricular dysfunction.
|
J Nucl Med
|
2003
|
0.79
|
|
133
|
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.
|
Ann Nucl Med
|
2013
|
0.79
|
|
134
|
Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination.
|
Mol Ther
|
2010
|
0.79
|
|
135
|
Generation of parametric image of regional myocardial blood flow using H(2)(15)O dynamic PET and a linear least-squares method.
|
J Nucl Med
|
2005
|
0.79
|
|
136
|
Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.
|
Am J Obstet Gynecol
|
2010
|
0.79
|
|
137
|
In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
|
Mol Imaging
|
2007
|
0.78
|
|
138
|
Biological properties of 2'-[18F]fluoroflumazenil for central benzodiazepine receptor imaging.
|
Nucl Med Biol
|
2005
|
0.78
|
|
139
|
Correlation of 11C-methionine PET and diffusion-weighted MRI: is there a complementary diagnostic role for gliomas?
|
Nucl Med Commun
|
2014
|
0.78
|
|
140
|
In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter.
|
Nucl Med Biol
|
2002
|
0.78
|
|
141
|
Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging.
|
Nucl Med Commun
|
2004
|
0.78
|
|
142
|
An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
|
Nucl Med Biol
|
2006
|
0.78
|
|
143
|
Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray.
|
Nucl Med Commun
|
2005
|
0.78
|
|
144
|
Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
|
Clin Nucl Med
|
2015
|
0.78
|
|
145
|
Dosimetry in leakage of (188)Re-DTPA during intracoronary balloon brachytherapy.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.77
|
|
146
|
A novel hNIS/tdTomato fusion reporter for visualizing the relationship between the cellular localization of sodium iodide symporter and its iodine uptake function under heat shock treatment.
|
Mol Imaging
|
2015
|
0.77
|
|
147
|
Primo vessel as a novel cancer cell migration path from testis with nanoparticle-labeled and GFP expressing cancer cells.
|
J Acupunct Meridian Stud
|
2013
|
0.77
|
|
148
|
Development of a dual membrane protein reporter system using sodium iodide symporter and mutant dopamine D2 receptor transgenes.
|
J Nucl Med
|
2007
|
0.77
|
|
149
|
Time course of functional recovery after coronary artery bypass grafting surgery according to the preoperative reversibility of perfusion impairment on myocardial SPECT.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.77
|
|
150
|
Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
|
Mol Cell Endocrinol
|
2006
|
0.77
|
|
151
|
Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model.
|
Mol Cancer Ther
|
2010
|
0.77
|
|
152
|
In vivo bioluminescence imaging of transplanted mesenchymal stem cells as a potential source for pancreatic regeneration.
|
Mol Imaging
|
2014
|
0.77
|
|
153
|
Evaluation of immediate post-stress wall motion on adenosine stress/rest thallium-201 gated myocardial SPECT.
|
Int J Cardiovasc Imaging
|
2005
|
0.77
|
|
154
|
The usefulness of repeated ictal SPET for the localization of epileptogenic zones in intractable epilepsy.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.77
|
|
155
|
Differential receptor targeting of liver cells using 99mTc-neoglycosylated human serum albumins.
|
Arch Pharm Res
|
2008
|
0.77
|
|
156
|
¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.
|
Nucl Med Commun
|
2015
|
0.77
|
|
157
|
Consideration of perfusion reserve in viability assessment by myocardial Tl-201 rest-redistribution SPECT: a quantitative study with dual-isotope SPECT.
|
J Nucl Cardiol
|
2002
|
0.77
|
|
158
|
Prognostic Implications of the SUVmax of Primary Tumors and Metastatic Lymph Node Measured by 18F-FDG PET in Patients With Uterine Cervical Cancer: A Meta-analysis.
|
Clin Nucl Med
|
2016
|
0.77
|
|
159
|
Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
|
Nucl Med Commun
|
2016
|
0.77
|
|
160
|
Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
|
J Nucl Med
|
2003
|
0.76
|
|
161
|
Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
|
Nucl Med Commun
|
2006
|
0.76
|
|
162
|
A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
|
Clin Nucl Med
|
2014
|
0.76
|
|
163
|
Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter.
|
Clin Cancer Res
|
2005
|
0.76
|
|
164
|
PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
|
Medicine (Baltimore)
|
2015
|
0.76
|
|
165
|
Feasibility of template-guided attenuation correction in cat brain PET imaging.
|
Mol Imaging Biol
|
2009
|
0.76
|
|
166
|
Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.75
|
|
167
|
Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient: A case report.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
168
|
Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.
|
Expert Opin Biol Ther
|
2015
|
0.75
|
|
169
|
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
170
|
Effect of ginseng saponins on enhanced dopaminergic transmission and locomotor hyperactivity induced by nicotine.
|
Neuropsychopharmacology
|
2005
|
0.75
|
|
171
|
Functional evaluation of parathyroid adenoma using 99mTc-MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity.
|
Nucl Med Commun
|
2014
|
0.75
|
|
172
|
Septal stunning by dipyridamole stress shown on quantitative gated perfusion SPECT in a child with hypertrophic cardiomyopathy.
|
Clin Nucl Med
|
2002
|
0.75
|
|
173
|
Incidental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological features?
|
Nucl Med Commun
|
2014
|
0.75
|
|
174
|
Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
|
Oncol Rep
|
2013
|
0.75
|
|
175
|
Cationic complex: (99m)Tc-N,N'-dimethyldiaminedithiol.
|
Nucl Med Biol
|
2002
|
0.75
|
|
176
|
Pulmonary artery sarcoma detected on F-18 FDG PET/CT as origin of multiple spinal metastases.
|
Clin Nucl Med
|
2011
|
0.75
|
|
177
|
Phase analysis of gated myocardial perfusion single-photon emission computed tomography after coronary artery bypass graft surgery: reflection of late reverse remodeling in patients with patent grafts after coronary artery bypass graft surgery.
|
Nucl Med Commun
|
2016
|
0.75
|
|
178
|
Use of granulocyte colony-stimulating factor for fluorine-18-fluorodeoxyglucose labeling in human leukocytes.
|
Nucl Med Commun
|
2011
|
0.75
|
|
179
|
Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study.
|
Nucl Med Commun
|
2016
|
0.75
|
|
180
|
Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
|
Appl Radiat Isot
|
2006
|
0.75
|
|
181
|
Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT.
|
Nucl Med Commun
|
2017
|
0.75
|
|
182
|
Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer.
|
Clin Nucl Med
|
2015
|
0.75
|
|
183
|
ARCCNM report for 2001-2002. Asian Regional Cooperative Council for Nuclear Medicine: a suitable model for the promotion of nuclear medicine in developing regions.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.75
|
|
184
|
Comparison of maximal elastance and systolic wall thickening using arterial tonometry and gated myocardial SPECT in patients undergoing coronary artery bypass grafting.
|
Appl Radiat Isot
|
2009
|
0.75
|
|
185
|
Extravasation of hydroxymethylene diphosphonate-induced subcutaneous inflammation, histologically demonstrated in BALB/c mice.
|
J Nucl Med
|
2010
|
0.75
|
|
186
|
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
|
Clin Nucl Med
|
2016
|
0.75
|
|
187
|
Relationship between apoptosis imaging and radioiodine therapy in tumor cells with different sodium iodide symporter gene expression.
|
Mol Imaging
|
2014
|
0.75
|
|
188
|
Synthesis and evaluation of benzothiophene derivatives as ligands for imaging beta-amyloid plaques in Alzheimer's disease.
|
Nucl Med Biol
|
2006
|
0.75
|